0001209191-19-024176.txt : 20190409 0001209191-19-024176.hdr.sgml : 20190409 20190409190038 ACCESSION NUMBER: 0001209191-19-024176 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190405 FILED AS OF DATE: 20190409 DATE AS OF CHANGE: 20190409 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Goldberg Jeff Marc CENTRAL INDEX KEY: 0001703061 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38137 FILM NUMBER: 19740373 MAIL ADDRESS: STREET 1: C/O AKCEA THERAPEUTICS STREET 2: 55 CAMBRIDGE PARKWAY, STE 100 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001662524 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472608175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 22 BOSTON WHARF RD STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-207-0202 MAIL ADDRESS: STREET 1: 22 BOSTON WHARF RD STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-04-05 0 0001662524 AKCEA THERAPEUTICS, INC. AKCA 0001703061 Goldberg Jeff Marc C/O AKCEA THERAPEUTICS, INC. 22 BOSTON WHARF ROAD, 9TH FLOOR BOSTON MA 02210 0 1 0 0 Chief Operating Officer Common Stock 2019-04-05 4 M 0 30000 6.48 A 32880 D Common Stock 2019-04-05 4 S 0 30000 31.71 D 2880 D Common Stock 2019-04-08 4 M 0 20000 6.48 A 22880 D Common Stock 2019-04-08 4 S 0 20000 31.7209 D 2880 D Stock Option (right to buy) 6.48 2019-04-05 4 M 0 30000 0.00 D 2025-12-15 Common Stock 30000 322250 D Stock Option (right to buy) 6.48 2019-04-08 4 M 0 20000 0.00 D 2025-12-15 Common Stock 20000 302250 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The weighted average sale price for the transaction reported was $31.7209, and the range of prices were between $31.71 and $31.85. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. The shares vest as follows: 1/4th of the shares vest one year after January 5, 2015; 1/48th of the shares vest monthly thereafter over the next three years. /s/ Jeffrey M. Goldberg 2019-04-09